Peters, Solange; Dafni, Urania; Boyer, Michael; De Ruysscher, Dirk; Faivre-Finn, Corinne; Felip, Enriqueta; Garrido, Pilar; Girard, Nicolas; Guckenberger, Matthias; Haanen, John; Le Pechoux, Cecile; Mornex, Francoise; Ozsahin, Mahmut; Paz-Ares, Luis; Planchard, David; Raben, David; Ramalingam, Suresh; Reck, Martin; Smit, Egbert; Stahel, Rolf; Stenzinger, Albrecht; Swanton, Charlie; Vallone, Stefania; Garassino, Marina C (2019). Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Annals of Oncology, 30(2):161-165.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Hematology
Health Sciences > Oncology |
Language: | English |
Date: | 1 February 2019 |
Deposited On: | 12 Feb 2019 15:37 |
Last Modified: | 06 Jun 2022 07:12 |
Publisher: | Oxford University Press |
ISSN: | 0923-7534 |
OA Status: | Hybrid |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/annonc/mdy553 |
PubMed ID: | 30624547 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-162596
Download
Article Networks
Authors, Affiliations, Collaborations
Université de Lausanne (UNIL), Lausanne, Switzerland
National and Kapodistrian University of Athens, School of Health Sciences, Athens, Greece
Chris O'Brien Lifehouse, Sydney, Australia
University Hospital Maastricht, Maastricht, Netherlands
University of Manchester, Manchester, United Kingdom
Vall d‘Hebron Institut de Oncologia, Barcelona, Spain
Hospital Ramon y Cajal, Madrid, Spain
Institut Curie, Paris, France
UniversitatsSpital Zurich, Zurich, Switzerland
The Netherlands Cancer Institute, Amsterdam, Netherlands
Stabilité génétique et oncogenèse, Villejuif, France
CHU de Lyon, Lyon, France
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Hospital Universitario 12 de Octubre, Madrid, Spain
Stabilité génétique et oncogenèse, Villejuif, France
University of Colorado Cancer Center, Aurora, United States
Emory University School of Medicine, Atlanta, United States
German Center for Lung Research, Grosshansdorf, Germany
The Netherlands Cancer Institute, Amsterdam, Netherlands
UniversitatsSpital Zurich, Zurich, Switzerland
Universitätsklinikum Heidelberg, Heidelberg, Germany
UCL Cancer Institute, London, United Kingdom
Lung Cancer Europe (LuCE), Bern, Switzerland
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milan, Italy